HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Partial androgen insensitivity: the Reifenstein syndrome revisited.

Abstract
We investigated eight patients with the Reifenstein syndrome to define the hormonal basis for this condition. The patients had normal or elevated concentrations of plasma androgens, normal production rates of testosterone and dihydrotestosterone, elevated serum levels of luteinizing hormone and normal 5alpha-reductase activity in skin fibroblasts. These findings indicate that the syndrome results from defective androgen action rather than from decreased androgen synthesis. The term "partial androgen insensitivity syndrome" describes this condition more accurately than a term based on clinical phenotype. Dihydrotestosterone binding studies in skin fibroblasts demonstrated two genetic variants similar to those reported in complete androgen insensitivity syndrome. One patient had a partial deficiency of cytoplasmic dihydrotestosterone binding, and four others had normal binding activity. The cause of the androgen insensitivity in the last four cases is unknown. Treatment with testosterone suppressed serum luteinizing hormone levels and promoted mild virilizing effects.
AuthorsJ A Amrhein, G J Klingensmith, P C Walsh, V A McKusick, C J Migeon
JournalThe New England journal of medicine (N Engl J Med) Vol. 297 Issue 7 Pg. 350-6 (Aug 18 1977) ISSN: 0028-4793 [Print] United States
PMID876326 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Androgens
  • Gonadotropins
  • Receptors, Androgen
  • Dihydrotestosterone
  • Testosterone
  • Luteinizing Hormone
  • Oxidoreductases
Topics
  • Adolescent
  • Adult
  • Aged
  • Androgens (blood, metabolism, physiology)
  • Cytoplasm (metabolism)
  • Dihydrotestosterone (blood, metabolism)
  • Disorders of Sex Development (blood, genetics, metabolism, physiopathology)
  • Female
  • Fibroblasts
  • Gonadotropins (blood)
  • Gynecomastia (complications)
  • Humans
  • Hypospadias (complications)
  • Luteinizing Hormone (blood)
  • Male
  • Middle Aged
  • Oxidoreductases (metabolism)
  • Protein Binding
  • Receptors, Androgen (metabolism)
  • Skin (metabolism)
  • Syndrome
  • Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: